ArticleScientific reports2025
Development of a novel rat model for pancreaticoduodenectomy.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pancreaticoduodenectomy (PD) is a complex surgical procedure associated with substantial postoperative risk. Despite its clinical significance, the lack of a standardized, cost-effective animal model hinders mechanistic research. Here, we aimed to establish a feasible and safe rat PD model. A simulated PD procedure was performed on Sprague-Dawley rats, including pancreaticojejunostomy (PJ), hepatojejunostomy (HJ), and gastrojejunostomy (GJ). The survival rate, surgical details, enzyme levels (amylase and lipase) and histopathological changes were analyzed. 7-day survival rate was 85.0% (51/60, 95% CI 0.739-0.919). The mean operation duration was 74.9 ± 12.3 min (PJ: 10.0 ± 2.8 min; HJ: 9.7 ± 3.9 min; GJ: 14.8 ± 4.9 min). Histological analysis revealed pancreatic injury at postoperative day (POD) 1, transient acinar-to-ductal metaplasia (ADM) at POD3 and restoration of acinar architecture by POD 7. Immunohistochemistry (IHC) staining demonstrated early acinar apoptosis (C-caspase-3) at POD1-3, CK19 upregulation with reduced amylase at POD3, and re-emergence of acinar markers (amylase) by POD7. Postoperative serum and ascites amylase/lipase levels were statistically elevated and recovered around day 5. This study successfully established a stable and economical rat PD model, providing a practical platform for postoperative mechanistic studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.